METAS

Advertisement
Jan 21 2025HEALTH

The Power of Combo Therapy: Pitstop-2 and 1, 6-Hexanediol in Lung Cancer

When cancer cells become aggressive, they change how they use energy. This is known as metabolic reprogramming. Two compounds, Pitstop-2 and 1, 6-hexanediol, have been shown to mess with this process. Pitstop-2 blocks some essential tasks like cell eating (endocytosis) and key transport jobs, while

reading time less than a minute
Jan 18 2025HEALTH

Pancreatic Tumor Surgery: How Many Lymph Nodes Matter?

Imagine you're having surgery to remove a tumor from your pancreas. Doctors want to know how many nearby lymph nodes to take out. Why? Because it can affect your chances of recovery. In a recent study, doctors looked into the best way to remove lymph nodes during this type of surgery for a specific

reading time less than a minute
Jan 15 2025HEALTH

The Sugar and Immune Cell Ratio: A New Way to Predict Outcomes in Metastatic Kidney Cancer

Finding reliable ways to predict how metastatic kidney cancer patients will respond to treatment is a big deal. Doctors need this info to decide on the best care plan. One thing they're looking at is the glucose-to-lymphocyte ratio (GLR). This is like a sugar to immune cells ratio. A Turkish group c

reading time less than a minute
Jan 14 2025HEALTH

Can Exercise Boost Health and Save Money for Breast Cancer Patients?

Imagine you're battling metastatic breast cancer (mBC). You're wondering if a supervised exercise program could do more than just keep you active. Researchers decided to test this idea. They conducted a study called the PREFERABLE-EFFECT trial. This trial compared a 9-month exercise program with usu

reading time less than a minute
Jan 11 2025BUSINESS

Meta Pivots Away from Inclusion Efforts, Shifting Focus

In a recent development, Meta has taken a step back from its diversity and inclusion initiatives. The company has informed its employees that they are no longer required to interview candidates from underrepresented backgrounds or prioritize diverse suppliers. This move marks a significant shift in

reading time less than a minute
Jan 08 2025TECHNOLOGY

Meta's New Note-Taking Approach Sparks Excitement

When asked about Meta’s choice to adopt a community notes model instead of relying on staff fact-checkers, X CEO Linda Yaccarino was thrilled. “That’s awesome! ” she exclaimed. The model, similar to X’s approach, lets users flag topics like immigration and gender identity, sparking broader discussio

reading time less than a minute
Jan 07 2025HEALTH

Delay issues in metastatic breast cancer: what you need to know

Ever noticed how people with early breast cancer often get quicker treatments? That's what scientists already know. But what about those with metastatic breast cancer (MBC), where it spreads to other parts of the body? Not much is known about why they face delays in getting care. This study is chang

reading time less than a minute
Jan 07 2025HEALTH

PET Imaging Goes Brain-Deep: New Insights into Cancer Spread

Brain metastases, the most common malignant tumors in the brain, pose a challenge for doctors trying to differentiate between recurring cancer and changes due to treatment. To address this, several prominent medical organizations have teamed up to create a new guideline. This guideline revolves arou

reading time less than a minute
Dec 31 2024HEALTH

AI & Stats: A New Approach to Managing Peritoneal Cancer Spread

Ever wondered how technology can help fight cancer? Scientists are exploring the use of artificial intelligence (AI) and statistics to better understand and manage peritoneal metastases (PM) resulting from gastrointestinal cancers. This fascinating research aims to find new ways to analyze and tackl

reading time less than a minute
Dec 23 2024HEALTH

New Hope for Advanced Breast Cancer: A Look at ADCs

Metastatic breast cancer is serious business. It's when cancer spreads from the breast to other parts of the body. There are two main types: hormone receptor-positive (HR+) and triple-negative (TN). For a long time, chemotherapy (CT) has been the standard treatment. But now, antibody-drug conjugates

reading time less than a minute